AxxessBio is pleased to announce that Health Sciences Authority (HSA) Singapore has granted the registration rights to supply TEPADINA® (thiotepa) 100mg and TEPADINA® (thiotepa) 15mg with the following indications:
- With or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients
- When high dose chemotherapy with HPCT support is appropriate for the treatment of breast cancer in adult patients and CNS tumours in paediatric patients
*Please refer to the local package insert for full prescribing information.
